報價延遲最少15分鐘:2024/05/17 02:21 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
0.7373 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-7.87/-1.61
|
|
企業價值
70.21M
|
| 資產負債 |
|
每股賬面淨值
-2.83
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
4.00K
|
|
每股收益
0.00
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2024/05/17 02:21 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology. |